Dr. Milan Mrksich also co-founded Arsenal Medical, ModuMab Therapeutics, and Lyra Therapeutics (NASDAQ: LYRA) and has held advisory positions throughout his career on the board of governors of Argonne National Laboratory, the Department of Defense’s Defense Advanced Research Projects Agency, and several academic and editorial boards. After 15 years at the University of Chicago, Dr. Mrksich joined Northwestern University and was named the Henry Wade Rogers Professor in 2011 and now serves as the Vice President for Research.
With his lab, Mrksich has published more than 200 papers and presented approximately 500 invited lectures on his work. Among the awards he has earned are the Searle Scholar Award, the Sloan Research Fellowship, the Dreyfus Teacher-Scholar Award, the American Chemical Society Arthur C. Cope Scholar Award, the iCON Innovator Award and the Pittsburgh Analytical Chemistry Award. He is also a fellow of the American Institute for Medical and Biological Engineering, and of the American Association for the Advancement of Science. Dr. Mrksich received his doctorate in chemistry from the California Institute of Technology and served as an American Cancer Society postdoctoral fellow at Harvard University.